Zurück zur Übersicht
Veröffentlicht am: 06.02.2020

Publikationen Publikationen 2011–2015

2015:

42. Frisbie DD: Autologous-conditioned serum: evidence for use in the knee. J Knee Surg. 2015 Feb; 28(1):63-6. doi: 10.1055/s-0034-1543956. Epub 2015 Jan 19. PubMed PMID: 25599270
41. Baselga J et al: Treatment of Osteoarthritis of the Knee with a Combination of Autologous Conditioned Serum and Physiotherapy: A Two-Year Observational Study. PLoS ONE 10(12): e0145551.
40. Geburek F et al.: Effect of a single injection of autologous conditioned serum (ACS) on tendon healing in equine naturally occurring tendinopathies; Stem Cell Research & Therapy 6:126 (2015)
39. Torrero JI, Martínez C: New developments in the treatment of osteoarthritis -focus on biologic agents. Open Access Rheumatol. 2015 Jul 22;7:33-43. eCollection 2015. Review. PubMed PMID: 27790043; PubMed Central PMCID: PMC5045124.

2014:

38. Astolfi M, McGuire K, Kaminski TW: The effectiveness of autologous conditioned serum in the treatment of knee osteoarthritis. J Sport Rehabil. 2014 Nov;23(4):365-9. doi: 10.1123/jsr.2013-0029. Epub 2014 May 2. Review. PubMed PMID: 24810293.
37. Beyzadeoglu T: Cytokines in Sports Medicine. ISAKOS NEWSLETTER 2014: Volume I. Current Concepts, 1–44.
36. Majewski M, von Wehren L, & Blanke F: Treatment Of Achillodynia With Local Injections Of Autologous Conditioned Serum (acs). British Journal of Sports Medicine, 48(Suppl_2), A38–A39. http://doi.org/10.1136/bjsports-2014-094114.60

2013:

35. Alvarez-Camino JC et al.: Use of autologous conditioned serum (ORTHOKINE) for the treatment of the degenerative osteoarthritis of the temporomandibular joint. Review of the literature. Med Oral Patol Oral Cir Bucal (2013) 18 (3): 433–438
34. Frizziero A et al.: Autologous conditioned serum for the treatment of osteoarthritis and other possible applications in musculoskeletal disorders. Br Med Bull (2013) 105: 169–184
33. Baltzer AWA et al.: A new treatment for hip osteoarthritis: clinical evidence for the efficacy of autologous conditioned serum. Orthop Rev (2013) 5(2):e13
32. Weisshaar MP, Gaji S: Signaling Proteins (Growth Factors and Cytokines) in Orthopaedics. Comparison of two blood processing techniques: ORTHOKINE® and ACP®. CORS congress 2013 Venice, Italy
31. Morgenstern DR et al.: Adjunctive Biological Treatment for Degenerative Hip Disease with Focal Chondro Labral Defects. ISHA Annual Meeting, Munich, Poster 58 (2013)

2012:

30. Heisterbach PE et al.: Effect of BMP-12, TGF-β1 and autologous conditioned serum on growth factor expression in Achilles tendon healing. Knee Surg Sports Traumatol Arthrosc (2012) 20(10): 1907–1914

2011:

29. Textor J: Autologous biologic treatment for equine musculoskeletal injuries: platelet-rich plasma and IL-1 receptor antagonist protein. Vet Clin North Am Equine Pract. 2011 Aug; 27(2): 275–298. doi: 10.1016/j.cveq.2011.05.001. PubMed PMID: 21872759
28. Darabos N et al.: Intraarticular application of autologous conditioned serum (ACS) reduces bone tunnel widening after ACL reconstructive surgery in a randomized controlled trial. Knee Surg Sports Traumatol Arthrosc (2011) 19: 36–46
27. Geburek F, Stadler P: Regenerative therapy for tendon and ligament disorders in horses. Terminology, production, biologic potential and in vitro effects. Tierarztl Prax Ausg G Grosstiere Nutztiere. 2011; 39(6): 373–83. Review. German. PubMed PMID: 22167082